In this interview from the 2012 American Society of Hematology (ASH) Annual Meeting Dr. Ajay Gopal, discusses a new study which looks into whether radio immunotherapy could be an improvement for patients with advanced lymphomas. He has pursued an approach to deliver targeted radiation by attaching a radioactive isotope to a monoclonal antibody which specifically targets B-cell lymphomas. They have escalated the dose to the maximum safe dose to deliver more radiation to the tumor sites. The trial replaced a standard high dose therapy regimen with target radiation using radio immunotherapy. Dr. Gopal shares the results of the study.